Westat has extensive experience with observational and epidemiologic study designs and methods. These studies often are used to estimate the incidence, prevalence, and risk factors associated with various health outcomes. They also study the effectiveness and safety of therapeutic interventions in real life settings.
Westat has conducted more than 300 epidemiologic studies during the past 30 years for many pharmaceutical companies and government agencies. Study designs include
Epidemiologic research methods are being used increasingly for registry and post-approval studies in response to Food and Drug Administration guidelines and requirements for post-marketing surveillance.
Late-phase studies supplement the information obtained from clinical trials by providing
Information collected from epidemiologic studies often includes data on the following
Westat’s experienced staff of epidemiologists and statisticians in the design and analysis of epidemiologic studies. Design considerations include constructing and using potentially complex sampling strategies to ensure the representativeness of the study population and the generalizability of the results.